More than half a billion Covid vaccine doses wasted after Emergent's Baltimore fiasco
New congressional committee findings released Thursday show that 135 million more coronavirus vaccine doses manufactured at Emergent BioSolutions’ Baltimore-based facility for Johnson & Johnson were designated for destruction due to quality deficiencies — bringing the total number of doses wasted due to the contractor’s failures to more than 525 million.
The new findings follow a committee report last May that uncovered damning new info on Emergent’s facility, which at one time was supposed to make hundreds of millions of doses for both J&J and AstraZeneca, and its interactions with the FDA.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
